Compare, Analyse Biocon Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ADCOCK INGRAM (S. Africa) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    ADCOCK INGRAM
EQUITY SHARE DATA
    BIOCON
Mar-19
ADCOCK INGRAM
Jun-14
BIOCON /
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs707309-   
Low Rs554223-   
Sales per share (Unadj.) Rs91.991.9-  
Earnings per share (Unadj.) Rs16.7-23.2-  
Cash flow per share (Unadj.) Rs24.2-19.2-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.672.1-  
Shares outstanding (eoy) m600.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.92.9 237.1%   
Avg P/E ratio x37.7-11.5 -328.6%  
P/CF ratio (eoy) x26.1-13.9 -188.3%  
Price / Book Value ratio x6.23.7 168.3%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,33044,866 843.2%   
No. of employees `0006.14.3 142.8%   
Total wages/salary Rs m11,6532,816 413.8%   
Avg. sales/employee Rs Th8,994.33,612.0 249.0%   
Avg. wages/employee Rs Th1,900.7655.9 289.8%   
Avg. net profit/employee Rs Th1,635.3-910.1 -179.7%   
INCOME DATA
Net Sales Rs m55,14415,506 355.6%  
Other income Rs m1,444109 1,329.8%   
Total revenues Rs m56,58815,615 362.4%   
Gross profit Rs m15,883-2,687 -591.1%  
Depreciation Rs m4,478669 669.1%   
Interest Rs m709420 168.8%   
Profit before tax Rs m12,140-3,668 -331.0%   
Minority Interest Rs m9-10 -88.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123229 926.3%   
Profit after tax Rs m10,026-3,907 -256.6%  
Gross profit margin %28.8-17.3 -166.2%  
Effective tax rate %17.5-6.2 -279.9%   
Net profit margin %18.2-25.2 -72.2%  
BALANCE SHEET DATA
Current assets Rs m48,22811,357 424.6%   
Current liabilities Rs m30,3766,390 475.4%   
Net working cap to sales %32.432.0 101.1%  
Current ratio x1.61.8 89.3%  
Inventory Days Days68111 61.6%  
Debtors Days Days86124 69.0%  
Net fixed assets Rs m64,1306,620 968.7%   
Share capital Rs m3,00072 4,167.0%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,98012,171 501.0%   
Long term debt Rs m15,7664,277 368.6%   
Total assets Rs m121,92422,992 530.3%  
Interest coverage x18.1-7.7 -234.4%   
Debt to equity ratio x0.30.4 73.6%  
Sales to assets ratio x0.50.7 67.1%   
Return on assets %8.8-15.2 -58.0%  
Return on equity %16.4-32.1 -51.2%  
Return on capital %16.8-19.8 -84.6%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,5461,324 872.3%  
From Investments Rs m-7,138-406 1,756.4%  
From Financial Activity Rs m-2,4173,882 -62.3%  
Net Cashflow Rs m2,1034,799 43.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.26 Rs / ZAR

Compare BIOCON With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: AUROBINDO PHARMA  VENUS REMEDIES  SHASUN PHARMA  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

India's Import Embargo on Defence Items, June Quarter Results, and Top Buzzing Stocks Today(Pre-Open)

Extending gains to the third straight day, Indian share markets witnessed buying interest throughout the day yesterday, amid sustained foreign fund inflows and positive cues from global markets.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

Is It Time to Book Profits in Gold and Silver? (Fast Profits Daily)

Aug 10, 2020

Gold and silver have delivered phenomenal returns this year. Is it time to take some money of the table?

This 20 Year Cycle Suggests Gold is Set for an August Rally (Profit Hunter)

Jul 31, 2020

The real reason why gold prices will go up more.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Aug 10, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 5-YR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

Can You Win a Stock Market Championship Using My Penny Stock Strategy? Let's Find Out

How to Use Price Action to Find High Conviction Trading Ideas

Why This Attractive 'Silver' Stock With 9% Dividends Is Not a Buy

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets

More Featured Videos

MARKET STATS